HEALTH● ELEVATEDSep 1 · Sep 1, 2026, 5:28 AM
Novartis halts autoimmune CAR-T trials following three patient deaths: WSJ
Seeking Alpha Tech · global
Novartis has halted trials for autoimmune CAR-T therapies after three patient deaths were reported. This action impacts the development of a new treatment type and raises concerns about patient safety in clinical trials.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH59m agoRecent virus outbreaks show urgent need to complete pandemic treaty, says WHO chiefEuroNews [en]HEALTH1h agoData reveals that Americans who vote live longer than those who don’tThe Independent WorldHEALTH1h agoFor years she suffered abdominal pains and they discovered she was carrying a stone baby in her wombClarínHEALTHBREAKING1h agoEbola kills over 5,300 in fastest-growing outbreak on recordEuroNews [en]